サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1470684

消化器感染症検査市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、予測、2024～2031年

Gastrointestinal Infection Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日: | 発行: Persistence Market Research | ページ情報: 英文 213 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
消化器感染症検査市場：製品タイプ別、エンドユーザー別、地域別 - 世界の産業分析、規模、シェア、成長、動向、予測、2024～2031年
出版日: 2024年04月22日
発行: Persistence Market Research
ページ情報: 英文 213 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchは、消化器感染症検査市場を徹底的に分析し、その世界の状況を詳述した包括的なレポートを提供しています。この詳細な出版物は、市場力学、動向、機会、課題に関する貴重な洞察を提供し、その構造の包括的な概要を提供します。独占データと統計に裏打ちされた本調査は、2024年から2031年までの消化器感染症検査市場の予想成長軌道を予測しています。

世界の消化器感染症検査市場は、消化器疾患の症例増加に牽引され、成長が見込まれています。2031年までには、CAGR4.9%で5億1,317万米ドルに達すると推定されます。

主な洞察

  • 消化器感染症検査市場規模（2024年）：4億4,456万米ドル
  • 市場予測金額（2031年）：5億1,317万米ドル
  • 世界市場成長率（CAGR、2024～2031年）：4.9%

消化器感染症検査市場 - 調査範囲：

消化器感染症検査市場の調査範囲は、業界情勢を形成する様々な要因の徹底的な分析を含みます。これには、検査方法、対象病原体、エンドユーザーセグメント、および地理的地域に基づくセグメンテーションが含まれます。本レポートは、市場規模、実績動向、現在のダイナミクス、特定期間内の将来の成長見通しに関する洞察を提供します。

さらに、市場拡大に影響を与える主要な市場促進要因・課題・機会・規制要因についても調査しています。主要企業のプロファイル、市場シェア評価、戦略的イニシアティブを含む競合情勢分析も含まれています。さらに、消化器感染症検査市場における新たな動向、技術的進歩、投資見通しについても掘り下げています。全体として、利害関係者に貴重な洞察を提供することで、情報に基づいた意思決定を促進し、世界の消化器感染症検査市場における機会を活用することを目的としています。

市場成長の促進要因：

消化器感染症検査市場の成長は様々な要因によって促進されます。まず、汚染された食品や水、不衛生な環境、感染因子の拡散などの要因に起因する消化器感染症の世界の蔓延の増加が、正確な診断検査に対する需要を促進しています。さらに、消化器感染症の早期発見と迅速な治療の重要性に関するヘルスケア専門家や一般住民の意識の高まりが、市場の成長をさらに後押ししています。

さらに、ポリメラーゼ連鎖反応（PCR）、イムノアッセイ、核酸増幅検査（NAAT）などの診断技術の進歩により、消化器感染症を引き起こすさまざまな病原体の迅速かつ正確な検出が可能になり、市場の普及を促進しています。さらに、予防ヘルスケア対策が重視されるようになり、規制当局による厳格な食品安全規制が実施されていることも、消化器感染症検査の需要に寄与しています。

さらに、旅行に関連した消化器疾患の発生率の増加や薬剤耐性病原体の出現は、堅牢な診断ソリューションの必要性を強調し、市場の成長を促進しています。さらに、分子診断技術とポイントオブケア検査（POCT）機器の統合により、検査の分散化が促進され、消化器感染症のタイムリーな診断と管理が可能になるため、市場の拡大を後押ししています。

市場抑制要因：

消化器感染症検査市場は、その有望な成長見通しにもかかわらず、成長を抑制する可能性のある特定の制約に直面しています。重要な課題の1つは、高度な診断検査施設へのアクセスが限られていることであり、特にヘルスケアのインフラが不十分な地方や遠隔地ではその傾向が顕著です。さらに、分子診断検査に関連する高コストや、一部の地域ではこれらの検査に対する償還政策がないことも、市場浸透の妨げになる可能性があります。

さらに、規制の複雑さや診断検査に対する厳格な品質保証措置の必要性は、新しい検査製品の規制当局による承認を求める市場関係者にとって課題となります。さらに、特定の診断検査の精度や信頼性、偽陽性や偽陰性の可能性に関する懸念が、医療提供者がこれらの検査ソリューションを採用することを躊躇させる可能性があります。

さらに、COVID-19のパンデミックは世界のヘルスケアシステムの混乱を招き、定期的な診断検査の遅れやヘルスケアの優先順位の転換を招き、市場の成長を一時的に鈍化させる可能性があります。市場の抑制要因を克服し、消化器感染症検査市場の潜在力を最大限に引き出すには、こうした課題に対処することが不可欠です。

機会：

消化器感染症検査市場には、成長とイノベーションの機会がいくつかあります。まず、個別化医療への注目の高まりと消化器感染症に対する標的療法の開発により、治療方針の決定と治療反応のモニタリングのためのコンパニオン診断検査の開発機会が創出されます。

さらに、複数の病原体を同時に検出できるマルチプレックス検査プラットフォームの採用が拡大していることから、消化器感染症の包括的な診断パネルを開発し、診断精度と効率を向上させる機会が市場プレーヤーにもたらされています。さらに、ポイントオブケア環境、特に資源が限られた環境や救急部門における迅速診断検査の需要の高まりは、ユーザーフレンドリーで費用対効果の高い検査ソリューションの開発機会をもたらしています。

さらに、マイクロ流体工学、バイオセンサー、人工知能（AI）などの診断技術の進歩は、感度、特異性、速度を向上させた革新的な診断プラットフォームを開発する機会を提供し、市場の成長を促進します。さらに、研究開発イニシアチブのための診断企業、医療提供者、学術機関の戦略的提携は、新規診断検査の開発を促進し、市場参入を加速することができます。

レポートが回答する主な質問

  • 消化器感染症検査市場の現在の規模と成長軌道は？
  • 市場の成長を促進する主な要因は何か？
  • 市場拡大を妨げる主な課題は何か？
  • 消化器感染症検査市場における利害関係者にはどのような機会が存在するか？
  • 市場情勢を形成する主要動向は何か？
  • 市場に影響を与える規制要因は何か、またそれらは市場力学にどのような影響を与えているか？

目次

第1章 エグゼクティブサマリー

第2章 市場イントロダクション

  • 市場定義
  • 市場分類

第3章 消化器感染症検査市場の機会分析

  • マクロ経済要因
  • 機会分析

第4章 市場背景

  • 消化器感染症の見通し
  • 市場力学
  • 主な動向

第5章 世界経済の見通し

  • 国内総生産：地域別・国別、2006～2023年
  • ヘルスケア費支出見通し

第6章 主要な包含事項

  • 疾病疫学・統計
  • 規制シナリオ
  • 価格分析と予測

第7章 世界の消化器感染症検査市場分析（2019～2023年）と予測（2022～2026年）：地域別

  • イントロダクション / 主な調査結果
  • 過去の市場規模と動向分析：地域別、2019～2023年
  • 市場規模予測：地域別、2022～2026年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 中国を除くアジア太平洋
    • 中国
    • 中東・アフリカ

第8章 世界の消化器感染症検査分析（2019～2023年）と予測（2022～2026年）：疾患株別、製品別、エンドユーザー別

  • イントロダクション / 主な調査結果
  • 過去の市場規模と動向分析：疾患株別、2019～2023年
    • 細菌株
    • ウイルス株
    • 寄生菌
  • 市場規模予測：製品別、2024～2031年
  • 市場魅力度分析：疾患株タイプ別
  • 過去の市場規模と動向分析：製品タイプ別、2019～2023年
    • 試薬キット
    • シーケンシングキット
    • 装置
  • 市場規模予測：製品タイプ別、2024～2031年
  • 市場魅力度分析：製品タイプ別
  • 過去の市場規模と動向分析：エンドユーザータイプ別、2019～2023年
    • 病院
    • クリニック/医療センター
    • 診断検査室
    • 調査機関
  • 市場規模予測：エンドユーザータイプ別、2024～2031年
  • 市場魅力度分析：製品タイプ別
  • 前年比成長分析：疾患株別、製品別、エンドユーザー別

第9章 北米の消化器感染症検査市場分析（2019～2023年）と予測（2024～2031年）

第10章 ラテンアメリカの消化器感染症検査市場分析（2019～2023年）と予測（2024～2031年）

第11章 欧州の消化器感染症検査市場分析（2019～2023年）と予測（2018～2026年）

第12章 中国を除くアジア太平洋の消化器感染症検査市場分析（2019～2023年）と予測（2024～2031年）

第13章 中国の消化器感染症検査市場分析（2019～2023年）と予測（2024～2031年）

  • イントロダクション
  • 過去の市場規模と動向分析：疾患株タイプ別、2019～2023年
    • 細菌株
    • ウイルス株
    • 寄生菌
  • 市場規模の予測：疾患株タイプ別、2024～2031年
  • 過去の市場規模の動向分析：製品別、2019～2023年
    • 試薬キット
    • 装置
  • 市場規模予測：検査タイプ別、2024～2031年
  • 過去の市場規模の動向分析：エンドユーザー別、2019～2023年
    • 病院
    • クリニック/医療センター
    • 診断検査室
    • 調査機関
  • 市場規模の予測：エンドユーザー別、2024～2031年
  • 市場の魅力分析

第14章 中東・アフリカの消化器感染症検査市場分析（2019～2023年）と予測（2024～2031年）

第15章 予測要因：関連性と影響

第16章 予測の前提条件

第17章 市場構造分析

  • 市場構造分析
  • 市場シェア分析（2023年）、主要企業別

第18章 競合分析

  • Becton, Dickinson and Company (BD)
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Bio-Rad Laboratories Inc.
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Luminex Corporation
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Hoffmann-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • bioMerieux SA
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Quidel Corporation
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Seegene Inc
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments
  • Genetic Signatures
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Key Developments

第19章 前提条件と使用される頭字語

第20章 調査手法

目次
Product Code: PMRREP17314

Persistence Market Research has conducted a thorough analysis of the Gastrointestinal Infection Testing Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Gastrointestinal Infection Testing Market spanning from 2024 to 2031.

The Global Gastrointestinal Infection Testing Market is poised for growth, driven by rising cases of digestive disorders. By 2031, it's estimated to reach $513.17 million at a CAGR of 4.9%.

Key Insights:

  • Gastrointestinal Infection Testing Market Size (2024): US$ 444.56 Mn
  • Projected Market Value (2031): US$ 513.17 Mn
  • Global Market Growth Rate (CAGR 2024-2031): 4.9%

Gastrointestinal Infection Testing Market - Report Scope:

The scope of the Gastrointestinal Infection Testing Market report entails a thorough analysis of various factors shaping the industry landscape. This encompasses segmentation based on testing methods, target pathogens, end-user segments, and geographical regions. The report provides insights into market size, historical trends, current dynamics, and future growth prospects within the specified period.

Moreover, it explores key market drivers, challenges, opportunities, and regulatory factors influencing market expansion. Competitive landscape analysis, including profiles of major players, market share assessment, and strategic initiatives, is also included. Additionally, the report delves into emerging trends, technological advancements, and investment prospects in the Gastrointestinal Infection Testing Market. Overall, it aims to offer stakeholders valuable insights to facilitate informed decision-making and capitalize on opportunities in the global Gastrointestinal Infection Testing Market.

Market Growth Drivers:

The growth of the Gastrointestinal Infection Testing Market is propelled by various factors. Firstly, the increasing prevalence of gastrointestinal infections worldwide, attributed to factors such as contaminated food and water, poor sanitation, and the spread of infectious agents, drives the demand for accurate diagnostic testing. Additionally, the rising awareness among healthcare professionals and the general population regarding the importance of early detection and prompt treatment of gastrointestinal infections further fuels market growth.

Furthermore, advancements in diagnostic technologies, such as polymerase chain reaction (PCR), immunoassays, and nucleic acid amplification tests (NAATs), enable rapid and accurate detection of a wide range of pathogens causing gastrointestinal infections, thereby driving market adoption. Moreover, the growing emphasis on preventive healthcare measures and the implementation of stringent food safety regulations by regulatory authorities contribute to the demand for gastrointestinal infection testing.

Additionally, the increasing incidence of travel-related gastrointestinal illnesses and the emergence of drug-resistant pathogens underscore the need for robust diagnostic solutions, driving market growth. Furthermore, the integration of molecular diagnostic techniques with point-of-care testing (POCT) devices facilitates decentralized testing and enables timely diagnosis and management of gastrointestinal infections, thereby boosting market expansion.

Market Restraints:

Despite its promising growth prospects, the Gastrointestinal Infection Testing Market faces certain constraints that may impede its growth. One significant challenge is the limited accessibility to advanced diagnostic testing facilities, particularly in rural and remote areas with inadequate healthcare infrastructure. Additionally, the high cost associated with molecular diagnostic tests and the lack of reimbursement policies for these tests in some regions may hinder market penetration.

Moreover, regulatory complexities and the need for stringent quality assurance measures for diagnostic tests pose challenges for market players seeking regulatory approval for new testing products. Furthermore, concerns regarding the accuracy and reliability of certain diagnostic tests, as well as the potential for false-positive or false-negative results, may deter healthcare providers from adopting these testing solutions.

Furthermore, the COVID-19 pandemic has disrupted healthcare systems globally, leading to delays in routine diagnostic testing and a shift in healthcare priorities, which may temporarily slow down market growth. Addressing these challenges will be essential for overcoming market restraints and unlocking the full potential of the Gastrointestinal Infection Testing Market.

Opportunities:

The Gastrointestinal Infection Testing Market offers several opportunities for growth and innovation. Firstly, the increasing focus on personalized medicine and the development of targeted therapies for gastrointestinal infections create opportunities for the development of companion diagnostic tests to guide treatment decisions and monitor treatment response.

Moreover, the growing adoption of multiplex testing platforms capable of detecting multiple pathogens simultaneously presents opportunities for market players to develop comprehensive diagnostic panels for gastrointestinal infections, thereby improving diagnostic accuracy and efficiency. Additionally, the rising demand for rapid diagnostic tests for point-of-care settings, particularly in resource-limited settings and emergency departments, presents opportunities for the development of user-friendly and cost-effective testing solutions.

Furthermore, advancements in diagnostic technologies, such as microfluidics, biosensors, and artificial intelligence (AI), offer opportunities to develop innovative diagnostic platforms with enhanced sensitivity, specificity, and speed, thereby driving market growth. Moreover, strategic collaborations between diagnostic companies, healthcare providers, and academic institutions for research and development initiatives can facilitate the development of novel diagnostic tests and accelerate market entry.

Key Questions Answered in Report::

  • What is the current size and growth trajectory of the Gastrointestinal Infection Testing Market?
  • What are the primary factors driving the growth of the market?
  • What are the major challenges hindering market expansion?
  • What opportunities exist for stakeholders in the Gastrointestinal Infection Testing Market?
  • What are the key trends shaping the market landscape?
  • What are the regulatory factors impacting the market, and how are they influencing market dynamics?

Competitive Intelligence and Business Strategy

Competitive intelligence plays a vital role in shaping effective business strategies within the Gastrointestinal Infection Testing Market. By closely monitoring competitors' actions, including their product offerings, pricing strategies, distribution channels, and marketing tactics, companies can gain valuable insights into market dynamics and identify opportunities for differentiation and growth.

A robust competitive intelligence framework enables businesses to anticipate market trends, customer preferences, and emerging competitive threats, allowing them to proactively adjust their strategies to stay ahead of the curve. This includes analyzing competitors' strengths and weaknesses to identify areas of competitive advantage and potential vulnerabilities to exploit.

Moreover, competitive intelligence informs strategic decision-making processes, such as product development, market positioning, and expansion efforts. By understanding competitors' market positions and customer perceptions, companies can tailor their offerings to address unmet needs and differentiate themselves in the marketplace effectively.

Furthermore, competitive intelligence informs risk assessment and mitigation strategies, enabling businesses to anticipate potential challenges and develop contingency plans to mitigate their impact. This includes monitoring regulatory developments, intellectual property issues, and geopolitical factors that may affect market dynamics and competitive positioning.

Key Companies Profiled

  • Becton, Dickinson and Company (BD)
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Hoffmann-La Roche Ltd.
  • bioMerieux SA
  • Quidel Corporation
  • Illumina, Inc.
  • Seegene Inc
  • Genetic Signatures

Gastrointestinal Infection Testing Market Categorization

Gastrointestinal Infection Testing Market by End User

  • Hospitals
  • Clinics/Medical Centers
  • Diagnostic Laboratories
  • Research Institutes

Gastrointestinal Infection Testing Market by Disease Strains

  • Bacterial Strains
  • Viral Strains
  • Parasitic Strains

Gastrointestinal Infection Testing Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Gastrointestinal Infection Testing Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Gastrointestinal Infection Outlook
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
  • 4.3. Key Trends

5. Global Economic Outlook

  • 5.1. Gross Domestic Product by Region & Country, 2006 - 2023
  • 5.2. Healthcare Spending Outlook

6. Key Inclusion

  • 6.1. Disease Epidemiology/Statistics
  • 6.2. Regulatory Scenario
  • 6.3. Pricing Analysis and Forecast

7. Global Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2022-2026, By Region

  • 7.1. Introduction/Key Findings
  • 7.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2019-2023
  • 7.3. Market Size (US$ Mn) Forecast By Region, 2022-2026
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. Asia Pacific Excluding China
    • 7.3.5. China
    • 7.3.6. Middle East & Africa

8. Global Gastrointestinal Infection Testing Analysis 2019-2023 and Forecast 2022-2026, By Disease Strains, By Product, and By End User

  • 8.1. Introduction/Key Findings
  • 8.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains, 2019-2023
    • 8.2.1. Bacterial Strain
      • 8.2.1.1. Clostridium difficile
      • 8.2.1.2. E. coli
      • 8.2.1.3. Salmonella
      • 8.2.1.4. Staphylococcus aureus
      • 8.2.1.5. Campylobacter
      • 8.2.1.6. Other Bacterial Strains
    • 8.2.2. Viral Strains
      • 8.2.2.1. Adenovirus
      • 8.2.2.2. Enterovirus
      • 8.2.2.3. Norovirus
      • 8.2.2.4. Rotavirus
      • 8.2.2.5. Sapovirus
      • 8.2.2.6. Other Viral Strains
    • 8.2.3. Parasitic Strains
      • 8.2.3.1. Cryptosporidium parvum
      • 8.2.3.2. Giardia lamblia
      • 8.2.3.3. Other Parasitic Strains
  • 8.3. Market Size (US$ Mn) Forecast By Product, 2024-2031
  • 8.4. Market Attractiveness Analysis by Disease Strains Type
  • 8.5. Historical Market Size (US$ Mn) Trend Analysis by Product Type, 2019-2023
    • 8.5.1. Reagent Kits
      • 8.5.1.1. PCR Detection Panels
        • 8.5.1.1.1. Norovirus Detection Panels
        • 8.5.1.1.2. Rotavirus Detection Panels
        • 8.5.1.1.3. Adenovirus Detection Panels
        • 8.5.1.1.4. Sapovirus Detection Panels
        • 8.5.1.1.5. Other Viral Detection Panels
        • 8.5.1.1.6. Parasitic Detection Panels
        • 8.5.1.1.7. Clostridium difficile Detection Panels
        • 8.5.1.1.8. Other Detection Panels
    • 8.5.2. Sequencing Kits
    • 8.5.3. Equipment
      • 8.5.3.1. Automated PCR Systems
      • 8.5.3.2. Sequencers
  • 8.6. Market Size (US$ Mn) Forecast By Product Type, 2024-2031
  • 8.7. Market Attractiveness Analysis by Product Type
  • 8.8. Historical Market Size (US$ Mn) Trend Analysis by End User Type, 2019-2023
    • 8.8.1. Hospitals
    • 8.8.2. Clinics/Medical Centers
    • 8.8.3. Diagnostic Laboratories
    • 8.8.4. Research Institutes
  • 8.9. Market Size (US$ Mn) Forecast By End User Type, 2024-2031
  • 8.10. Market Attractiveness Analysis by Product Type
  • 8.11. Y-o-Y Growth Analysis by Disease Strains, by Product, and by End User

9. North America Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis by Country, 2019-2023
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 9.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
    • 9.4.1. Bacterial Strain
      • 9.4.1.1. Clostridium difficile
      • 9.4.1.2. E. coli
      • 9.4.1.3. Salmonella
      • 9.4.1.4. Staphylococcus aureus
      • 9.4.1.5. Campylobacter
      • 9.4.1.6. Other Bacterial Strains
    • 9.4.2. Viral Strains
      • 9.4.2.1. Adenovirus
      • 9.4.2.2. Enterovirus
      • 9.4.2.3. Norovirus
      • 9.4.2.4. Rotavirus
      • 9.4.2.5. Sapovirus
      • 9.4.2.6. Other Viral Strains
    • 9.4.3. Parasitic Strains
      • 9.4.3.1. Cryptosporidium parvum
      • 9.4.3.2. Giardia lamblia
      • 9.4.3.3. Other Parasitic Strains
  • 9.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
  • 9.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
    • 9.6.1. Reagent Kits
      • 9.6.1.1. PCR Detection Panels
        • 9.6.1.1.1. Norovirus Detection Panels
        • 9.6.1.1.2. Rotavirus Detection Panels
        • 9.6.1.1.3. Adenovirus Detection Panels
        • 9.6.1.1.4. Sapovirus Detection Panels
        • 9.6.1.1.5. Other Viral Detection Panels
        • 9.6.1.1.6. Parasitic Detection Panels
        • 9.6.1.1.7. Clostridium difficile Detection Panels
        • 9.6.1.1.8. Other Detection Panels
      • 9.6.1.2. Sequencing Kits
    • 9.6.2. Equipment
      • 9.6.2.1. Automated PCR Systems
      • 9.6.2.2. Sequencers
  • 9.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
  • 9.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
    • 9.8.1. Hospitals
    • 9.8.2. Clinics/Medical Centers
    • 9.8.3. Diagnostic Laboratories
    • 9.8.4. Research Institutes
  • 9.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 9.10. Market Attractiveness Analysis
    • 9.10.1. By Country
    • 9.10.2. By Disease Strain Type
    • 9.10.3. By Product
    • 9.10.4. By End User
  • 9.11. Market Attractiveness Analysis

10. Latin America Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 10.1. Introduction
  • 10.2. Regional Market Trends
  • 10.3. Historical Market Size (US$ Mn) Trends Analysis by Country, 2019-2023
    • 10.3.1. Argentina
    • 10.3.2. Brazil
    • 10.3.3. Mexico
    • 10.3.4. Rest of Latin America
  • 10.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 10.5. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
    • 10.5.1. Bacterial Strain
      • 10.5.1.1. Clostridium difficile
      • 10.5.1.2. E. coli
      • 10.5.1.3. Salmonella
      • 10.5.1.4. Staphylococcus aureus
      • 10.5.1.5. Campylobacter
      • 10.5.1.6. Other Bacterial Strains
    • 10.5.2. Viral Strains
      • 10.5.2.1. Adenovirus
      • 10.5.2.2. Enterovirus
      • 10.5.2.3. Norovirus
      • 10.5.2.4. Rotavirus
      • 10.5.2.5. Sapovirus
      • 10.5.2.6. Other Viral Strains
    • 10.5.3. Parasitic Strains
      • 10.5.3.1. Cryptosporidium parvum
      • 10.5.3.2. Giardia lamblia
      • 10.5.3.3. Other Parasitic Strains
  • 10.6. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
  • 10.7. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
    • 10.7.1. Reagent Kits
      • 10.7.1.1. PCR Detection Panels
        • 10.7.1.1.1. Norovirus Detection Panels
        • 10.7.1.1.2. Rotavirus Detection Panels
        • 10.7.1.1.3. Adenovirus Detection Panels
        • 10.7.1.1.4. Sapovirus Detection Panels
        • 10.7.1.1.5. Other Viral Detection Panels
        • 10.7.1.1.6. Parasitic Detection Panels
        • 10.7.1.1.7. Clostridium difficile Detection Panels
        • 10.7.1.1.8. Other Detection Panels
      • 10.7.1.2. Sequencing Kits
    • 10.7.2. Equipment
      • 10.7.2.1. Automated PCR Systems
      • 10.7.2.2. Sequencers
  • 10.8. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
  • 10.9. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
    • 10.9.1. Hospitals
    • 10.9.2. Clinics/Medical Centers
    • 10.9.3. Diagnostic Laboratories
    • 10.9.4. Research Institutes
  • 10.10. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 10.11. Market Attractiveness Analysis
    • 10.11.1. By Country
    • 10.11.2. By Disease Strains Type
    • 10.11.3. By Product
    • 10.11.4. By End User
  • 10.12. Market Attractiveness Analysis

11. Europe Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2018-2026

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2019-2023
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Russia
    • 11.2.7. Rest of Europe
  • 11.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 11.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
    • 11.4.1. Bacterial Strain
      • 11.4.1.1. Clostridium difficile
      • 11.4.1.2. E. coli
      • 11.4.1.3. Salmonella
      • 11.4.1.4. Staphylococcus aureus
      • 11.4.1.5. Campylobacter
      • 11.4.1.6. Other Bacterial Strains
    • 11.4.2. Viral Strains
      • 11.4.2.1. Adenovirus
      • 11.4.2.2. Enterovirus
      • 11.4.2.3. Norovirus
      • 11.4.2.4. Rotavirus
      • 11.4.2.5. Sapovirus
      • 11.4.2.6. Other Viral Strains
    • 11.4.3. Parasitic Strains
      • 11.4.3.1. Cryptosporidium parvum
      • 11.4.3.2. Giardia lamblia
      • 11.4.3.3. Other Parasitic Strains
  • 11.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
  • 11.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
    • 11.6.1. Reagent Kits
      • 11.6.1.1. PCR Detection Panels
        • 11.6.1.1.1. Norovirus Detection Panels
        • 11.6.1.1.2. Rotavirus Detection Panels
        • 11.6.1.1.3. Adenovirus Detection Panels
        • 11.6.1.1.4. Sapovirus Detection Panels
        • 11.6.1.1.5. Other Viral Detection Panels
        • 11.6.1.1.6. Parasitic Detection Panels
        • 11.6.1.1.7. Clostridium difficile Detection Panels
        • 11.6.1.1.8. Other Detection Panels
      • 11.6.1.2. Sequencing Kits
    • 11.6.2. Equipment
      • 11.6.2.1. Automated PCR Systems
      • 11.6.2.2. Sequencers
  • 11.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
  • 11.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
    • 11.8.1. Hospitals
    • 11.8.2. Clinics/Medical Centers
    • 11.8.3. Diagnostic Laboratories
    • 11.8.4. Research Institutes
  • 11.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 11.10. Market Attractiveness Analysis
    • 11.10.1. By Country
    • 11.10.2. By Disease Strains Type
    • 11.10.3. By Product
    • 11.10.4. By End User
  • 11.11. Market Attractiveness Analysis

12. Asia Pacific Excluding China Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2019-2023
    • 12.2.1. Japan
    • 12.2.2. India
    • 12.2.3. Australia and New Zealand
    • 12.2.4. Rest of Asia Pacific Excluding China
  • 12.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 12.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
    • 12.4.1. Bacterial Strain
      • 12.4.1.1. Clostridium difficile
      • 12.4.1.2. E. coli
      • 12.4.1.3. Salmonella
      • 12.4.1.4. Staphylococcus aureus
      • 12.4.1.5. Campylobacter
      • 12.4.1.6. Other Bacterial Strains
    • 12.4.2. Viral Strains
      • 12.4.2.1. Adenovirus
      • 12.4.2.2. Enterovirus
      • 12.4.2.3. Norovirus
      • 12.4.2.4. Rotavirus
      • 12.4.2.5. Sapovirus
      • 12.4.2.6. Other Viral Strains
    • 12.4.3. Parasitic Strains
      • 12.4.3.1. Cryptosporidium parvum
      • 12.4.3.2. Giardia lamblia
      • 12.4.3.3. Other Parasitic Strains
  • 12.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
  • 12.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
    • 12.6.1. Reagent Kits
      • 12.6.1.1. PCR Detection Panels
        • 12.6.1.1.1. Norovirus Detection Panels
        • 12.6.1.1.2. Rotavirus Detection Panels
        • 12.6.1.1.3. Adenovirus Detection Panels
        • 12.6.1.1.4. Sapovirus Detection Panels
        • 12.6.1.1.5. Other Viral Detection Panels
        • 12.6.1.1.6. Parasitic Detection Panels
        • 12.6.1.1.7. Clostridium difficile Detection Panels
        • 12.6.1.1.8. Other Detection Panels
      • 12.6.1.2. Sequencing Kits
    • 12.6.2. Equipment
      • 12.6.2.1. Automated PCR Systems
      • 12.6.2.2. Sequencers
  • 12.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
  • 12.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
    • 12.8.1. Hospitals
    • 12.8.2. Clinics/Medical Centers
    • 12.8.3. Diagnostic Laboratories
    • 12.8.4. Research Institutes
  • 12.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 12.10. Market Attractiveness Analysis
    • 12.10.1. By Country
    • 12.10.2. By Disease Strains Type
    • 12.10.3. By Product
    • 12.10.4. By End User
  • 12.11. Market Attractiveness Analysis

13. China Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
    • 13.2.1. Bacterial Strain
      • 13.2.1.1. Clostridium difficile
      • 13.2.1.2. E. coli
      • 13.2.1.3. Salmonella
      • 13.2.1.4. Staphylococcus aureus
      • 13.2.1.5. Campylobacter
      • 13.2.1.6. Other Bacterial Strains
    • 13.2.2. Viral Strains
      • 13.2.2.1. Adenovirus
      • 13.2.2.2. Enterovirus
      • 13.2.2.3. Norovirus
      • 13.2.2.4. Rotavirus
      • 13.2.2.5. Sapovirus
      • 13.2.2.6. Other Viral Strains
    • 13.2.3. Parasitic Strains
      • 13.2.3.1. Cryptosporidium parvum
      • 13.2.3.2. Giardia lamblia
      • 13.2.3.3. Other Parasitic Strains
  • 13.3. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
  • 13.4. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
    • 13.4.1. Reagent Kits
      • 13.4.1.1. PCR Detection Panels
        • 13.4.1.1.1. Norovirus Detection Panels
        • 13.4.1.1.2. Rotavirus Detection Panels
        • 13.4.1.1.3. Adenovirus Detection Panels
        • 13.4.1.1.4. Sapovirus Detection Panels
        • 13.4.1.1.5. Other Viral Detection Panels
        • 13.4.1.1.6. Parasitic Detection Panels
        • 13.4.1.1.7. Clostridium difficile Detection Panels
        • 13.4.1.1.8. Other Detection Panels
      • 13.4.1.2. Sequencing Kits
    • 13.4.2. Equipment
      • 13.4.2.1. Automated PCR Systems
      • 13.4.2.2. Sequencers
  • 13.5. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
  • 13.6. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
    • 13.6.1. Hospitals
    • 13.6.2. Clinics/Medical Centers
    • 13.6.3. Diagnostic Laboratories
    • 13.6.4. Research Institutes
  • 13.7. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Country
    • 13.8.2. By Disease Strains Type
    • 13.8.3. By Product
    • 13.8.4. By End User
  • 13.9. Market Attractiveness Analysis

14. Middle East & Africa Gastrointestinal Infection Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2019-2023
    • 14.2.1. GCC Countries
    • 14.2.2. South Africa
    • 14.2.3. Rest of MEA
  • 14.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 14.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Strains Type, 2019-2023
    • 14.4.1. Bacterial Strain
      • 14.4.1.1. Clostridium difficile
      • 14.4.1.2. E. coli
      • 14.4.1.3. Salmonella
      • 14.4.1.4. Staphylococcus aureus
      • 14.4.1.5. Campylobacter
      • 14.4.1.6. Other Bacterial Strains
    • 14.4.2. Viral Strains
      • 14.4.2.1. Adenovirus
      • 14.4.2.2. Enterovirus
      • 14.4.2.3. Norovirus
      • 14.4.2.4. Rotavirus
      • 14.4.2.5. Sapovirus
      • 14.4.2.6. Other Viral Strains
    • 14.4.3. Parasitic Strains
      • 14.4.3.1. Cryptosporidium parvum
      • 14.4.3.2. Giardia lamblia
      • 14.4.3.3. Other Parasitic Strains
  • 14.5. Market Size (US$ Mn) Forecast By Disease Strains Type, 2024-2031
  • 14.6. Historical Market Size (US$ Mn) Trend Analysis by Product, 2019-2023
    • 14.6.1. Reagent Kits
      • 14.6.1.1. PCR Detection Panels
        • 14.6.1.1.1. Norovirus Detection Panels
        • 14.6.1.1.2. Rotavirus Detection Panels
        • 14.6.1.1.3. Adenovirus Detection Panels
        • 14.6.1.1.4. Sapovirus Detection Panels
        • 14.6.1.1.5. Other Viral Detection Panels
        • 14.6.1.1.6. Parasitic Detection Panels
        • 14.6.1.1.7. Clostridium difficile Detection Panels
        • 14.6.1.1.8. Other Detection Panels
      • 14.6.1.2. Sequencing Kits
    • 14.6.2. Equipment
      • 14.6.2.1. Automated PCR Systems
      • 14.6.2.2. Sequencers
  • 14.7. Market Size (US$ Mn) Forecast By Test Type, 2024-2031
  • 14.8. Historical Market Size (US$ Mn) Trend Analysis by End User, 2019-2023
    • 14.8.1. Hospitals
    • 14.8.2. Clinics/Medical Centers
    • 14.8.3. Diagnostic Laboratories
    • 14.8.4. Research Institutes
  • 14.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
  • 14.10. Market Attractiveness Analysis
    • 14.10.1. By Country
    • 14.10.2. By Disease Strains Type
    • 14.10.3. By Product
    • 14.10.4. By End User
  • 14.11. Market Attractiveness Analysis

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Market Structure Analysis

  • 17.1. Market Structure Analysis
  • 17.2. Market Share Analysis (2023), By Key Players

18. Competition Analysis

  • 18.1. Becton, Dickinson and Company (BD)
    • 18.1.1. Company Overview
    • 18.1.2. Product Portfolio
    • 18.1.3. Key Financials
    • 18.1.4. Key Developments
  • 18.2. Thermo Fisher Scientific Inc.
    • 18.2.1. Company Overview
    • 18.2.2. Product Portfolio
    • 18.2.3. Key Financials
    • 18.2.4. Key Developments
  • 18.3. Bio-Rad Laboratories Inc.
    • 18.3.1. Company Overview
    • 18.3.2. Product Portfolio
    • 18.3.3. Key Financials
    • 18.3.4. Key Developments
  • 18.4. Luminex Corporation
    • 18.4.1. Company Overview
    • 18.4.2. Product Portfolio
    • 18.4.3. Key Financials
    • 18.4.4. Key Developments
  • 18.5. Hoffmann-La Roche Ltd.
    • 18.5.1. Company Overview
    • 18.5.2. Product Portfolio
    • 18.5.3. Key Financials
    • 18.5.4. Key Developments
  • 18.6. bioMerieux SA
    • 18.6.1. Company Overview
    • 18.6.2. Product Portfolio
    • 18.6.3. Key Financials
    • 18.6.4. Key Developments
  • 18.7. Quidel Corporation
    • 18.7.1. Company Overview
    • 18.7.2. Product Portfolio
    • 18.7.3. Key Financials
    • 18.7.4. Key Developments
  • 18.8. Illumina, Inc.
    • 18.8.1. Company Overview
    • 18.8.2. Product Portfolio
    • 18.8.3. Key Financials
    • 18.8.4. Key Developments
  • 18.9. Seegene Inc
    • 18.9.1. Company Overview
    • 18.9.2. Product Portfolio
    • 18.9.3. Key Financials
    • 18.9.4. Key Developments
  • 18.10. Genetic Signatures
    • 18.10.1. Company Overview
    • 18.10.2. Product Portfolio
    • 18.10.3. Key Financials
    • 18.10.4. Key Developments

19. Assumptions and Acronyms Used

20. Research Methodology